Veradermics wins at growing hair with oral Rogaine in first key test as a public company
Veradermics has succeeded in its first major test as a newly-minted public company. The biotech's form of oral Rogaine cleared the bar in a Phase 2/3 trial in men with mild-to-moderate pattern hair loss, producing ...
April 27, 2026 07:00 AM EDT R&DPharma Veradermics wins at growing hair with oral Rogaine in late-stage trial Kyle LaHucik Biotech Correspondent Veradermics has succeeded in its first major test as a newly-minted public company. The biotech’s form of oral Rogaine cleared the bar in a Phase … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that